Valerion Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Valerion General Information

Description

Provider of bio-therapeutics services intended for the treatment of orphan genetic muscle diseases of patients. The company offers an antibody-mediated delivery platform to target specific tissues that enhance intracellular delivery of active therapeutic payloads via a transport mechanism that is present in muscle and neurons, thereby enabling clinicians to avail a novel way to treat a number of diseases with limited or no current therapeutic options.

Contact Information

Formerly Known As
4s3 Bioscience
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Main Street
  • Suite 110
  • Concord, MA 01742
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • 100 Main Street
  • Suite 110
  • Concord, MA 01742
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Valerion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Out of Business 30-Jun-2021 Completed Out of Business
11. Later Stage VC (Series C) 01-Jan-2016 Completed Generating Revenue
10. Later Stage VC (Series B) 01-Jan-2015 Completed Generating Revenue
9. Debt - General 01-Jun-2013 Completed Generating Revenue
8. Grant 30-May-2013 Completed Generating Revenue
7. Early Stage VC (Series A) 05-Mar-2012 Completed Generating Revenue
6. Grant Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2011 Completed Generating Revenue
4. Debt - General 25-Jun-2010 $2M Completed Generating Revenue
3. Grant 01-May-2010 $260K $2M Completed Generating Revenue
To view Valerion’s complete valuation and funding history, request access »

Valerion Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Valerion’s complete cap table history, request access »

Valerion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of bio-therapeutics services intended for the treatment of orphan genetic muscle diseases of patients. The comp
Drug Delivery
Concord, MA
2 As of 2021

Boston, MA
 

Barcelona, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Valerion Competitors (79)

One of Valerion’s 79 competitors is Entrada Therapeutics, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Entrada Therapeutics Formerly VC-backed Boston, MA
Minoryx Venture Capital-Backed Barcelona, Spain
Lexeo Therapeutics Formerly VC-backed New York, NY
Glycomine Venture Capital-Backed San Carlos, CA
Meditope Biosciences Formerly VC-backed Pasadena, CA
You’re viewing 5 of 79 competitors. Get the full list »

Valerion Patents

Valerion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210395716-A1 Methods and compositions for treatment of protein aggregation-based disorders Inactive 11-Oct-2018
WO-2020077297-A1 Methods and compositions for treatment of protein aggregation-based disorders Inactive 11-Oct-2018
AU-2019236270-A1 Methods and compositions for treatment of polyglucosan disorders Inactive 15-Mar-2018
CA-3093922-A1 Methods and compositions for treatment of polyglucosan disorders Pending 15-Mar-2018
EP-3765062-A1 Methods and compositions for treatment of polyglucosan disorders Pending 15-Mar-2018 A61P3/08
To view Valerion’s complete patent history, request access »

Valerion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valerion FAQs

  • When was Valerion founded?

    Valerion was founded in 2007.

  • Where is Valerion headquartered?

    Valerion is headquartered in Concord, MA.

  • What is the size of Valerion?

    Valerion has 2 total employees.

  • What industry is Valerion in?

    Valerion’s primary industry is Drug Delivery.

  • Is Valerion a private or public company?

    Valerion is a Private company.

  • What is Valerion’s current revenue?

    The current revenue for Valerion is .

  • How much funding has Valerion raised over time?

    Valerion has raised $47.9M.

  • Who are Valerion’s competitors?

    Entrada Therapeutics, Minoryx, Lexeo Therapeutics, Glycomine, and Meditope Biosciences are some of the 79 competitors of Valerion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process